210
Views
171
CrossRef citations to date
0
Altmetric
Research Article

Irritable Bowel Syndrome Prevalence Varies Enormously Depending on the Employed Diagnostic Criteria: Comparison of Rome II Versus Previous Criteria in a General Population

Pages 1155-1161 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Magdy El-Salhy, Tanisa Patcharatrakul, Jan Gunnar Hatlebakk, Trygve Hausken, Odd Helge Gilja & Sutep Gonlachanvit. (2017) Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome. Scandinavian Journal of Gastroenterology 52:12, pages 1331-1339.
Read now
Magdy El-Salhy, Tanisa Patcharatrakul, Jan Gunnar Hatlebakk, Trygve Hausken, Odd Helge Gilja & Sutep Gonlachanvit. (2017) Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome. Scandinavian Journal of Gastroenterology 52:6-7, pages 691-697.
Read now
Chalotte Heinsvig Poulsen, Lene Falgaard Eplov, Carsten Hjorthøj, Marie Eliasen, Jeanette Frost Ebstrup, Sine Skovbjerg, Andreas Schröder & Torben Jørgensen. (2016) Gastrointestinal symptoms related to the irritable bowel syndrome – a longitudinal population-based register study. Scandinavian Journal of Gastroenterology 51:4, pages 420-426.
Read now
Deborah M. Waters, Alexander Mauch, Aidan Coffey, Elke K. Arendt & Emanuele Zannini. (2015) Lactic Acid Bacteria as a Cell Factory for the Delivery of Functional Biomolecules and Ingredients in Cereal-Based Beverages: A Review. Critical Reviews in Food Science and Nutrition 55:4, pages 503-520.
Read now
Caroline Canavan, Joe West & Timothy Card. (2014) The epidemiology of irritable bowel syndrome. Clinical Epidemiology 6, pages 71-80.
Read now
Guy Boeckxstaens, Pere Clavé, Enrico S Corazziari & Jan Tack. (2014) Irritable bowel syndrome: focus on otilonium bromide. Expert Review of Gastroenterology & Hepatology 8:2, pages 131-137.
Read now
Markku T. Hillilä, Niilo J. Färkkilä & Martti A. Färkkilä. (2010) Societal costs for irritable bowel syndrome – a population based study. Scandinavian Journal of Gastroenterology 45:5, pages 582-591.
Read now
Susanna A. Walter, Lars Kjellström, Henry Nyhlin, Nicholas J. Talley & Lars Agréus. (2010) Assessment of normal bowel habits in the general adult population: the Popcol study. Scandinavian Journal of Gastroenterology 45:5, pages 556-566.
Read now
Markku T. Hillilä, Matti T. Siivola & Martti A. Färkkilä. (2007) Comorbidity and use of health-care services among irritable bowel syndrome sufferers. Scandinavian Journal of Gastroenterology 42:7, pages 799-806.
Read now
Per Olav Vandvik, Stian Lydersen & Per G. Farup. (2006) Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scandinavian Journal of Gastroenterology 41:6, pages 650-656.
Read now
A. H. Oberndorff-Klein Woolthuis, R.-J. M. Brummer, N. J. de Wit, J. W. M. Muris & R. W. Stockbrügger. (2004) Irritable bowel syndrome in general practice: an overview. Scandinavian Journal of Gastroenterology 39:241, pages 17-22.
Read now
C. Le Pen, P. Ruszniewski, A.‐F. Gaudin, M. Amouretti, G. Bommelaer, J. Frexinos, T. Poynard, F. Maurel, G. Priol & C. Bertin. (2004) The burden cost of French patients suffering from irritable bowel syndrome. Scandinavian Journal of Gastroenterology 39:4, pages 336-343.
Read now

Articles from other publishers (158)

Caroline Rometsch, Giovanni Mansueto, Frederic Maas Genannt Bermpohl, Alexandra Martin & Fiammetta Cosci. (2024) Prevalence of functional disorders across Europe: a systematic review and meta-analysis. European Journal of Epidemiology.
Crossref
Antonio M. Caballero‐Mateos. (2023) Methodological considerations and prevalence trends in disorders of gut–brain interaction: Lessons from comparative studies. Neurogastroenterology & Motility 35:11.
Crossref
Ximeng Wang & Jiande DZ Chen. (2023) Therapeutic potential and mechanisms of sacral nerve stimulation for gastrointestinal diseases. Journal of Translational Internal Medicine 11:2, pages 115-127.
Crossref
Joel Flores‐Arriaga, María C. Aso, Arantzazu Izagirre, Ami D. Sperber, Olafur S. Palsson, Shrikant I. Bangdiwala, Ángel Lanas, Luis Bujanda, Beatriz Lobo, Carmen Alonso‐Cotoner, Álex Sánchez‐Pla & Javier Santos. (2023) Prevalence and description of disorders of gut–brain interaction in Spain according to the results of the Rome Foundation Global Epidemiology Study . Neurogastroenterology & Motility 35:6.
Crossref
Fermín Mearin, Miquel Sans & Agustín Balboa. (2022) Relevancia y necesidades del síndrome del intestino irritable (SII): comparación con la enfermedad inflamatoria intestinal (EII). (Por favor, si no te interesa el SII, léelo.). Gastroenterología y Hepatología 45:10, pages 789-798.
Crossref
Fermín Mearin, Miquel Sans & Agustín Balboa. (2022) Relevance and needs of irritable bowel syndrome (IBS): Comparison with inflammatory bowel disease (IBD). (Please, if you are not interested in IBS, read it.). Gastroenterología y Hepatología (English Edition) 45:10, pages 789-798.
Crossref
Christopher J. Black, Lesley A. Houghton & Alexander C. Ford. (2022) Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities. Neurogastroenterology & Motility 34:11.
Crossref
Yong Sung Kim & Suck Chei Choi. (2022) Socioeconomic Disparities: A Possible Clue to a Puzzle Encompassing Organic to Functional Gastrointestinal Disorders. Journal of Neurogastroenterology and Motility 28:4, pages 512-514.
Crossref
Christopher J. Black. (2021) Review article: Diagnosis and investigation of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 54:S1.
Crossref
Duc Trong Quach, Khoa Tien Vu & Khien Van Vu. (2021) Prevalence, clinical characteristics, and management of irritable bowel syndrome in Vietnam: A scoping review. JGH Open 5:11, pages 1227-1235.
Crossref
Daniel Nilsson & Bodil Ohlsson. (2021) Gastrointestinal Symptoms and Irritable Bowel Syndrome Are Associated With Female Sex and Smoking in the General Population and With Unemployment in Men. Frontiers in Medicine 8.
Crossref
Dipesh H Vasant, Peter A Paine, Christopher J Black, Lesley A Houghton, Hazel A Everitt, Maura Corsetti, Anurag Agrawal, Imran Aziz, Adam D Farmer, Maria P Eugenicos, Rona Moss-Morris, Yan Yiannakou & Alexander C Ford. (2021) British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 70:7, pages 1214-1240.
Crossref
Durmuş Özkul, İbrahim Güney, Fatih Saçkan, Yasemin Coşkun Yavuz, Nedim Yilmaz Selcuk & Halil Z. Tonbul. (2020) Irritable bowel syndrome frequency and related factors in hemodialysis patients. Hemodialysis International 24:3, pages 359-366.
Crossref
Jakub Fichna. 2020. A Comprehensive Overview of Irritable Bowel Syndrome. A Comprehensive Overview of Irritable Bowel Syndrome 1 7 .
Judy NeeKatherine SalleyAndrew G. LudwigThomas SommersSarah BallouEve TakazawaSarah DuehrenPrashant SinghJohanna IturrinoJesse KatonHa-Neul LeeVikram RanganAnthony J. Lembo. (2019) Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome. Clinical and Translational Gastroenterology 10:12, pages e00110.
Crossref
Magdy El‑Salhy, Odd Gilja & Jan Hatlebakk. (2019) Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting. Molecular Medicine Reports.
Crossref
Alexander C. Ford. 2019. Evidence‐based Gastroenterology and Hepatology 4e. Evidence‐based Gastroenterology and Hepatology 4e 306 331 .
Fermín Mearin, Antonio M. Caballero, Jordi Serra, Carles Brotons, Ana Tantiñà, Esther Fort, Francisco J. Martínez-Cerezo, Antonia Perelló, Gloria Sánchez-Antolín, Enrique Rey, Ramón Angós Musgo, Ruth Berdier, Blas Gómez-Rodríguez, Pere Clavé, Mónica García-Alonso, Pere Torán-Monserrat & Jan Tack. (2019) A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain. Gastroenterología y Hepatología 42:3, pages 141-149.
Crossref
Fermín Mearin, Antonio M. Caballero, Jordi Serra, Carles Brotons, Ana Tantiñà, Esther Fort, Francisco J. Martínez-Cerezo, Antonia Perelló, Gloria Sánchez-Antolín, Enrique Rey, Ramón Angós Musgo, Ruth Berdier, Blas Gómez-Rodríguez, Pere Clavé, Mónica García-Alonso, Pere Torán-Monserrat & Jan Tack. (2019) A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain. Gastroenterología y Hepatología (English Edition) 42:3, pages 141-149.
Crossref
Matthew Krouwel, Kate Jolly & Sheila Greenfield. (2019) How do people with refractory irritable bowel syndrome perceive hypnotherapy: Qualitative study protocol. European Journal of Integrative Medicine 26, pages 50-55.
Crossref
Liuqin Jiang, Nina Zhang, Shengai Zhang & Jiande DZ Chen. (2019) Sacral nerve stimulation with optimized parameters improves visceral hypersensitivity in rats mediated via the autonomic pathway. Molecular Pain 15, pages 174480691988065.
Crossref
Muhammed Mustafa Uzan, Abdullah Ozan Polat, Gamze Sarıkaya Ozan, Dilek Toprak, Ezgi Karasu, Dilek Sarıkaya & Haluk Mergen. (2018) Irritable Bowel Syndrome Prevalence and Sociodemographic, Clinical and Lifestyle Features of Patients Admitted to Family Medicine Policlinic. Ankara Medical Journal, pages 690-698.
Crossref
J. Y. Chang, A. E. Almazar, G. Richard LockeIIIIII, J. J. Larson, E. J. Atkinson, N. J. Talley & Y. A. Saito. (2018) Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome. Neurogastroenterology & Motility 30:9.
Crossref
Masudur M. Rahman, Uday Chand Ghoshal, Shamima Sultana, Md Golam Kibria, Nigar Sultana, Zeenat Arefin Khan, Faruque Ahmed, Mahmud Hasan, Tahmeed Ahmed & Shafiqul Alam Sarker. (2018) Long-Term Gastrointestinal Consequences are Frequent Following Sporadic Acute Infectious Diarrhea in a tropical country: A Prospective cohort Study. American Journal of Gastroenterology 113:9, pages 1363-1375.
Crossref
Matthew Krouwel, Sheila Greenfield, Amanda Farley, Tariq Ismail & Kate Jolly. (2018) Factors which affect the efficacy of hypnotherapy for IBS: Protocol for a systematic review and meta-regression. European Journal of Integrative Medicine 21, pages 58-62.
Crossref
Fermín Mearin. (2017) Irritable Bowel Syndrome: Pain in Spain. American Journal of Gastroenterology 112:12, pages 1768-1769.
Crossref
Yeong Yeh Lee, Chandramouli Annamalai & Satish S. C. Rao. (2017) Post-Infectious Irritable Bowel Syndrome. Current Gastroenterology Reports 19:11.
Crossref
Bodil Ohlsson. (2017) The role of smoking and alcohol behaviour in management of functional gastrointestinal disorders. Best Practice & Research Clinical Gastroenterology 31:5, pages 545-552.
Crossref
Ami D Sperber, Dan Dumitrascu, Shin Fukudo, Charles Gerson, Uday C Ghoshal, Kok Ann Gwee, A Pali S Hungin, Jin-Yong Kang, Chen Minhu, Max Schmulson, Arkady Bolotin, Michael Friger, Tamar Freud & William Whitehead. (2017) The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut 66:6, pages 1075-1082.
Crossref
Isabel Vera & F. Javier Júdez. (2017) Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. The SEPD perspective. Revista Española de Enfermedades Digestivas.
Crossref
Charlotte Markert, Kerstin Suarez-Hitz, Ulrike Ehlert & Urs M. Nater. (2016) Endocrine dysregulation in women with irritable bowel syndrome according to Rome II criteria. Journal of Behavioral Medicine 39:3, pages 519-526.
Crossref
D. Guagnozzi, Á. Arias & A. J. Lucendo. (2016) Systematic review with meta‐analysis: diagnostic overlap of microscopic colitis and functional bowel disorders. Alimentary Pharmacology & Therapeutics 43:8, pages 851-862.
Crossref
J. Schwille‐Kiuntke, P. Enck, A. V. Polster, M. Gaile, P. G. Kremsner & P. Zanger. (2015) Postinfectious irritable bowel syndrome after travelers' diarrhea – a cohort study. Neurogastroenterology & Motility 27:8, pages 1147-1155.
Crossref
J. Schwille‐Kiuntke, N. Mazurak & P. Enck. (2015) Systematic review with meta‐analysis: post‐infectious irritable bowel syndrome after travellers' diarrhoea. Alimentary Pharmacology & Therapeutics 41:11, pages 1029-1037.
Crossref
D. Le Pluart, J.‐M. Sabaté, M. Bouchoucha, S. Hercberg, R. Benamouzig & C. Julia. (2015) Functional gastrointestinal disorders in 35 447 adults and their association with body mass index. Alimentary Pharmacology & Therapeutics 41:8, pages 758-767.
Crossref
Dan Carter, Marc Beer-Gabel, Dorit Tzur, Gad Levy, Estela Derazne, Ben Novis & Arnon Afek. (2015) Predictive Factors for the Diagnosis of Irritable Bowel Syndrome in a Large Cohort of 440,822 Young Adults. Journal of Clinical Gastroenterology 49:4, pages 300-305.
Crossref
Janne Fassov, Lilli Lundby, Jonas Worsøe, Steen Buntzen, Søren Laurberg & Klaus Krogh. (2014) A randomised, controlled study of small intestinal motility in patients treated with sacral nerve stimulation for irritable bowel syndrome. BMC Gastroenterology 14:1.
Crossref
S. Ludidi, Z. Mujagic, D. Jonkers, D. Keszthelyi, M. Hesselink, J. Kruimel, J. Conchillo & A. Masclee. (2014) Markers for visceral hypersensitivity in patients with irritable bowel syndrome. Neurogastroenterology & Motility 26:8, pages 1104-1111.
Crossref
Janne L. Fassov, Lilli Lundby, Søren Laurberg, Steen Buntzen & Klaus Krogh. (2014) A Randomized, Controlled, Crossover Study of Sacral Nerve Stimulation for Irritable Bowel Syndrome. Annals of Surgery 260:1, pages 31-36.
Crossref
Enrique Rey, Agustín Balboa & Fermín Mearin. (2014) Chronic Constipation, Irritable Bowel Syndrome With Constipation and Constipation With Pain/Discomfort: Similarities and Differences. American Journal of Gastroenterology 109:6, pages 876-884.
Crossref
Rok Seon Choung & Yuri A. Saito. 2014. GI Epidemiology. GI Epidemiology 222 234 .
Shira Maguen, Erin Madden, Beth Cohen, Daniel Bertenthal & Karen Seal. (2014) ASSOCIATION OF MENTAL HEALTH PROBLEMS WITH GASTROINTESTINAL DISORDERS IN IRAQ AND AFGHANISTAN VETERANS. Depression and Anxiety 31:2, pages 160-165.
Crossref
Danuta Chmielewska-Wilkoń. (2014) Otilonium bromide in irritable bowel syndrome: A dose-ranging randomized double-blind placebo-controlled trial. World Journal of Gastroenterology 20:34, pages 12283.
Crossref
Mamta Rajput & Sushma Kumari Saini. (2014) Prevalence of Constipation Among the General Population. Gastroenterology Nursing 37:6, pages 425-429.
Crossref
I.W. FongI. W. Fong. 2014. The Role of Microbes in Common Non-Infectious Diseases. The Role of Microbes in Common Non-Infectious Diseases 1 27 .
Alexander C. Ford, Premysl Bercik, David G. Morgan, Carolina Bolino, Maria Ines Pintos–Sanchez & Paul Moayyedi. (2013) Validation of the Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Gastroenterology 145:6, pages 1262-1270.e1.
Crossref
Kristin A. Zernicke, Tavis S. Campbell, Philip K. Blustein, Tak S. Fung, Jillian A. Johnson, Simon L. Bacon & Linda E. Carlson. (2012) Mindfulness-Based Stress Reduction for the Treatment of Irritable Bowel Syndrome Symptoms: A Randomized Wait-list Controlled Trial. International Journal of Behavioral Medicine 20:3, pages 385-396.
Crossref
Eamonn M.M. Quigley. 2013. Irritable Bowel Syndrome. Irritable Bowel Syndrome 37 49 .
Stefan Müller‐Lissner. 2013. Irritable Bowel Syndrome. Irritable Bowel Syndrome 23 36 .
Alexander C. Ford. 2013. Irritable Bowel Syndrome. Irritable Bowel Syndrome 1 21 .
Guy Boeckxstaens, Enrico S. Corazziari, Fermín Mearin & Jan Tack. (2012) IBS and the role of otilonium bromide. International Journal of Colorectal Disease 28:3, pages 295-304.
Crossref
Natasha A. Koloski & Nicholas J. Talley. 2013. Women and Health. Women and Health 1353 1365 .
Magdy El-Salhy. (2012) Irritable bowel syndrome: Diagnosis and pathogenesis. World Journal of Gastroenterology 18:37, pages 5151-5163.
Crossref
Fermín Mearin & Brian E. Lacy. (2012) Diagnostic criteria in IBS: useful or not?. Neurogastroenterology & Motility 24:9, pages 791-801.
Crossref
J. Dang, A. Ardila‐Hani, M. M. Amichai, K. Chua & M. Pimentel. (2012) Systematic review of diagnostic criteria for IBS demonstrates poor validity and utilization of Rome III. Neurogastroenterology & Motility 24:9, pages 853.
Crossref
Rebecca M Lovell & Alexander C Ford. (2012) Effect of Gender on Prevalence of Irritable Bowel Syndrome in the Community: Systematic Review and Meta-Analysis. American Journal of Gastroenterology 107:7, pages 991-1000.
Crossref
Rebecca M. Lovell & Alexander C. Ford. (2012) Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis. Clinical Gastroenterology and Hepatology 10:7, pages 712-721.e4.
Crossref
Alexander C Ford, David Forman, Alastair G Bailey, Anthony T R Axon & Paul Moayyedi. (2012) Effect of Dyspepsia on Survival: A Longitudinal 10-Year Follow-Up Study. American Journal of Gastroenterology 107:6, pages 912-921.
Crossref
Eamonn M. M. Quigley, Hussein Abdel-Hamid, Giovanni Barbara, Shobna J. Bhatia, Guy Boeckxstaens, Roberto De Giorgio, Michel Delvaux, Douglas A. Drossman, Amy E. Foxx-Orenstein, Francisco Guarner, Kok-Ann Gwee, Lucinda A. Harris, A. Pali S. Hungin, Richard H. Hunt, John E. Kellow, Igor L. Khalif, Wolfgang Kruis, Greger Lindberg, Carolina Olano, Joaquim P. Moraes-Filho, Lawrence R. Schiller, Max Schmulson, Magnus Simrén & Christian Tzeuton. (2012) A Global Perspective on Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 46:5, pages 356-366.
Crossref
Emanuele Sinagra, Claudia Romano & Mario Cottone. (2012) Psychopharmacological Treatment and Psychological Interventions in Irritable Bowel Syndrome. Gastroenterology Research and Practice 2012, pages 1-11.
Crossref
S. M. Barratt, J. S. Leeds, K. Robinson, A. J. Lobo, M. E. McAlindon & D. S. Sanders. (2011) Prodromal Irritable Bowel Syndrome May Be Responsible for Delays in Diagnosis in Patients Presenting with Unrecognized Crohn?s Disease and Celiac Disease, but Not Ulcerative Colitis. Digestive Diseases and Sciences 56:11, pages 3270-3275.
Crossref
Mariam Aguas, Vicente Garrigues, Guillermo Bastida, Pilar Nos, Vicente Ortiz, Alberto Fernandez & Julio Ponce. (2011) Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD). Journal of Crohn's and Colitis 5:3, pages 227-233.
Crossref
Hyun-Tai Lee & Byung Joo Kim. (2011) Trimebutine as a modulator of gastrointestinal motility. Archives of Pharmacal Research 34:6, pages 861-864.
Crossref
Susanna A. Walter, Lars Kjellström, Nicholas J. Talley, Anna Nixon Andreasson, Henry Nyhlin & Lars Agréus. (2010) Prospective Diary Evaluation of Unexplained Abdominal Pain and Bowel Dysfunction: A Population-Based Colonoscopy Study. Digestive Diseases and Sciences 56:5, pages 1444-1451.
Crossref
Uday C Ghoshal & Prabhat Ranjan. (2011) Post‐infectious irritable bowel syndrome: The past, the present and the future. Journal of Gastroenterology and Hepatology 26:s3, pages 94-101.
Crossref
Alexander C. Ford & Nicholas J. Talley. (2011) Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. Journal of Gastroenterology 46:4, pages 421-431.
Crossref
Rok Seon Choung & G. Richard LockeIIIIII. (2011) Epidemiology of IBS. Gastroenterology Clinics of North America 40:1, pages 1-10.
Crossref
Govind K Makharia, Anil K Verma, Ritvik Amarchand, Anil Goswami, Prashant Singh, Abhishek Agnihotri, Faizul Suhail & Anand Krishnan. (2011) Prevalence of Irritable Bowel Syndrome: A Community Based Study From Northern India. Journal of Neurogastroenterology and Motility 17:1, pages 82-87.
Crossref
Stefan Müller-Lissner, Eckhard Schäfer & Anke Kondla. (2011) Symptoms and Their Interpretation in Patients Self-Treating Abdominal Cramping and Pain with a Spasmolytic (Butylscopolamine Bromide)—A Pharmacy-Based Survey. Pharmacology & Pharmacy 02:02, pages 82-87.
Crossref
Aldona Dlugosz, Hans Törnblom, Ghazaleh Mohammadian, Gareth Morgan, Béla Veress, Benjamin Edvinsson, Gunnar Sandström & Greger Lindberg. (2010) Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome. BMC Gastroenterology 10:1.
Crossref
Full-Young Chang, Ching-Liang Lu & Tseng-Shing Chen. (2010) The Current Prevalence of Irritable Bowel Syndrome in Asia. Journal of Neurogastroenterology and Motility 16:4, pages 389-400.
Crossref
Sarah Khan & Lin Chang. (2010) Diagnosis and management of IBS. Nature Reviews Gastroenterology & Hepatology 7:10, pages 565-581.
Crossref
Alexander C Ford, Paul Moayyedi & Nicholas J Talley. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology 355 376 .
Dong Won Park & Oh Young Lee. (2010) Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?: Author's Reply. Journal of Neurogastroenterology and Motility 16:3, pages 343-344.
Crossref
Moo In Park. (2010) Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?. Journal of Neurogastroenterology and Motility 16:3, pages 342.
Crossref
Peter R. StregeLei ShaArthur BeyderCheryl E. BernardEdward Perez-Reyes, Stefano Evangelista, Simon J. GibbonsJoseph H. SzurszewskiGianrico Farrugia. (2010) T-type Ca 2+ channel modulation by otilonium bromide . American Journal of Physiology-Gastrointestinal and Liver Physiology 298:5, pages G706-G713.
Crossref
Dong Won Park, Oh Young Lee, Sung Gon Shim, Dae Won Jun, Kang Nyeong Lee, Hye Young Kim, Hang Lak Lee, Byung Chul Yoon & Ho Soon Choi. (2010) The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III. Journal of Neurogastroenterology and Motility 16:2, pages 186-193.
Crossref
Marroon Thabane, Marko Simunovic, Noori Akhtar-Danesh, Amit X Garg, William F Clark, Stephen M Collins, Marina Salvadori & John K Marshall. (2010) An Outbreak of Acute Bacterial Gastroenteritis Is Associated With an Increased Incidence of Irritable Bowel Syndrome in Children. American Journal of Gastroenterology 105:4, pages 933-939.
Crossref
Marcel Slockers. (2012) Let op zorgwekkende zorgmijders. Huisarts en wetenschap 53:4, pages 239-239.
Crossref
C. J. Bijkerk, N. J. de Wit, A. W. Hoes, J. W. M. Muris, J. A. Knottnerus & P. J. Whorwell. (2012) Oplosbare of niet-oplosbare vezels: wat werkt beter bij het prikkelbaredarmsyndroom?. Huisarts en wetenschap 53:4, pages 195-202.
Crossref
Graeme D Smith, Doug T Steinke, Kay I Penny, Moira Kinnear & Ian D Penman. (2010) Health‐related quality of life and symptom classification in patients with irritable bowel syndrome. Journal of Nursing and Healthcare of Chronic Illness 2:1, pages 4-12.
Crossref
Oh Young Lee. (2010) Prevalence and Risk Factors of Irritable Bowel Syndrome in Asia. Journal of Neurogastroenterology and Motility 16:1, pages 5-7.
Crossref
R. Moss-Morris, L. McAlpine, L. P. Didsbury & M. J. Spence. (2009) A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care. Psychological Medicine 40:1, pages 85-94.
Crossref
J. Gunnarsson & M. Simrén. (2009) Peripheral factors in the pathophysiology of irritable bowel syndrome. Digestive and Liver Disease 41:11, pages 788-793.
Crossref
E. Rey & N.J. Talley. (2009) Irritable bowel syndrome: Novel views on the epidemiology and potential risk factors. Digestive and Liver Disease 41:11, pages 772-780.
Crossref
Kok‐Ann Gwee, Ching‐Liang Lu & Uday Chand Ghoshal. (2009) Epidemiology of irritable bowel syndrome in Asia: Something old, something new, something borrowed. Journal of Gastroenterology and Hepatology 24:10, pages 1601-1607.
Crossref
S. LEE, J. WU, Y. L. MA, A. TSANG, W.‐J. GUO & J. SUNG. (2009) Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Alimentary Pharmacology & Therapeutics 30:6, pages 643-651.
Crossref
Judy R. Rees. 2009. Sequelae and Long-Term Consequences of Infectious Diseases. Sequelae and Long-Term Consequences of Infectious Diseases 53 68 .
Fermín Mearin, Francisco Guarner & Elena Verdú. (2009) Probióticos y aparato digestivo. Evidencias actuales. Gastroenterología y Hepatología 32, pages 1-14.
Crossref
Cristina Almansa, Enrique Rey, Raquel García Sánchez, Ángel Álvarez Sánchez & Manuel Díaz–Rubio. (2009) Prevalence of Functional Gastrointestinal Disorders in Patients With Fibromyalgia and the Role of Psychologic Distress. Clinical Gastroenterology and Hepatology 7:4, pages 438-445.
Crossref
Panagiotis Katsinelos, Georgia Lazaraki, Jannis Kountouras, George Paroutoglou, Irini Oikonomidou, Kostas Mimidis, Christos Koutras, George Gelas, Konstantinos Tziomalos, Christos Zavos, Ioannis Pilpilidis & Grigoris Chatzimavroudis. (2009) Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece. European Journal of Gastroenterology & Hepatology 21:2, pages 183-189.
Crossref
M?nica Perona. (2009) ?La fibra mejora o empeora el s?ndrome del intestino irritable?. Gastroenterolog?a y Hepatolog?a 32:2, pages 118-119.
Crossref
Enrique Rey, Mónica García-Alonso, Marta Moreno-Ortega, Cristina Almansa, Angel Alvarez-Sanchez & Manuel Díaz-Rubio. (2008) Influence of Psychological Distress on Characteristics of Symptoms in Patients with GERD: The Role of IBS Comorbidity. Digestive Diseases and Sciences 54:2, pages 321-327.
Crossref
Marroon Thabane & John K Marshall. (2009) Post-infectious irritable bowel syndrome. World Journal of Gastroenterology 15:29, pages 3591.
Crossref
Enrique Rey, Marta Moreno Ortega, Monica Olga Garcia Alonso & Manuel Diaz-Rubio. (2009) Constructive thinking, rational intelligence and irritable bowel syndrome. World Journal of Gastroenterology 15:25, pages 3106.
Crossref
R. E Casiday, A. Hungin, C. S Cornford, N. J de Wit & M. T Blell. (2008) GPs' explanatory models for irritable bowel syndrome: a mismatch with patient models?. Family Practice 26:1, pages 34-39.
Crossref
C.J. Bijkerk, J.W.M. Muris, J.A. Knottnerus, A.W. Hoes & N.J. de Wit. (2008) Randomized patients in IBS research had different disease characteristics compared to eligible and recruited patients. Journal of Clinical Epidemiology 61:11, pages 1176-1181.
Crossref
Enrique Rey, Monica Olga García-Alonso, Marta Moreno-Ortega, Angel Alvarez-Sanchez & Manuel Diaz-Rubio. (2008) Determinants of Quality of Life in Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 42:9, pages 1003-1009.
Crossref
Jenny Gunnarsson & Magnus Simrén. (2008) Efficient diagnosis of suspected functional bowel disorders. Nature Clinical Practice Gastroenterology & Hepatology 5:9, pages 498-507.
Crossref
Alexander C. Ford, David Forman, Alastair G. Bailey, Anthony T. R. Axon & Paul Moayyedi. (2008) Irritable Bowel Syndrome: A 10-Yr Natural History of Symptoms and Factors That Influence Consultation Behavior. The American Journal of Gastroenterology 103:5, pages 1229-1239.
Crossref
Ami D. Sperber, Carolyn Blank Morris, Lev Greemberg, Shrikant I. Bangdiwala, David Goldstein, Eyal Sheiner, Yefim Rusabrov, Yuming Hu, Miriam Katz, Tami Freud, Anat Neville & Douglas A. Drossman. (2008) Development of Abdominal Pain and IBS Following Gynecological Surgery: A Prospective, Controlled Study. Gastroenterology 134:1, pages 75-84.
Crossref
John E. Morley. (2007) Constipation and Irritable Bowel Syndrome in the Elderly. Clinics in Geriatric Medicine 23:4, pages 823-832.
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Mary K. Wojczynski, Kari E. North, Nancy L. Pedersen & Patrick F. Sullivan. (2007) Irritable Bowel Syndrome: A Co-Twin Control Analysis. The American Journal of Gastroenterology 102:10, pages 2220-2229.
Crossref
M. THABANE, D. T. KOTTACHCHI & J. K. MARSHALL. (2007) Systematic review and meta‐analysis: the incidence and prognosis of post‐infectious irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 26:4, pages 535-544.
Crossref
Ami D. Sperber, Pesach Shvartzman, Michael Friger & Alex Fich. (2007) A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the ???true??? prevalence of irritable bowel syndrome?. European Journal of Gastroenterology & Hepatology 19:6, pages 441-447.
Crossref
Fermín Mearin. (2007) Tratamiento farmacológico del síndrome del intestino irritable: una necesidad no cubierta. Gastroenterología y Hepatología 30:3, pages 130-137.
Crossref
Ferm?n Mearin. (2007) S?ndrome del intestino irritable: nuevos criterios de Roma III. Medicina Cl?nica 128:9, pages 335-343.
Crossref
Full‐Young Chang & Ching‐Liang Lu. (2006) Irritable bowel syndrome in the 21st century: Perspectives from Asia or South‐east Asia. Journal of Gastroenterology and Hepatology 22:1, pages 4-12.
Crossref
Dieter Genser. 2007. Psychosomatik in der Gastroenterologie und Hepatologie. Psychosomatik in der Gastroenterologie und Hepatologie 165 182 .
Agust??n Balboa, Ferm??n Mearin, Xavier Bad??a, Jaume Benavent, Antonio Mar??a Caballero, Jos?? Enrique Dom??nguez-Mu??oz, Vicente Garrigues, Jos?? Mar??a Piqu??Montse Roset, Mercedes Cucala & Montse Figueras. (2006) Impact of upper digestive symptoms in patients with irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 18:12, pages 1271-1277.
Crossref
Delnaz Roshandel, Mohammadreza Rezailashkajani, Sepideh Shafaee & Mohammad Reza Zali. (2006) Symptom patterns and relative distribution of functional bowel disorders in 1,023 gastroenterology patients in Iran. International Journal of Colorectal Disease 21:8, pages 814-825.
Crossref
Sera Tort, Agustín Balboa, Mercè Marzo, Ricard Carrillo, Miguel Mínguez, Javier Valdepérez, Pablo Alonso-Coello, Juan José Mascort, Juan Ferrándiz, Xavier Bonfill, Josep M. Piqué & Fermín Mearin. (2006) Guía de práctica clínica sobre el síndrome del intestino irritable. Gastroenterología y Hepatología 29:8, pages 467-521.
Crossref
E.M.M. Quigley, P. Bytzer, R. Jones & F. Mearin. (2006) Irritable bowel syndrome: The burden and unmet needs in Europe. Digestive and Liver Disease 38:10, pages 717-723.
Crossref
E. M. M. QUIGLEY, G. R. LOCKE, S. MUELLER‐LISSNER, L. G. PAULO, G. N. TYTGAT, I. HELFRICH & E. SCHAEFER. (2006) Prevalence and management of abdominal cramping and pain: a multinational survey. Alimentary Pharmacology & Therapeutics 24:2, pages 411-419.
Crossref
Josep M. Piqu??ngel Lanas. (2006) S?ndrome del intestino irritable: una enfermedad con una elevada carga socioecon?mica y sanitaria. Atenci?n Primaria 38:2, pages 69-71.
Crossref
Marc J. Zuckerman, Giang Nguyen, Hoi Ho, Luat Nguyen & Gavin G. Gregory. (2006) A Survey of Irritable Bowel Syndrome in Vietnam Using the Rome Criteria. Digestive Diseases and Sciences 51:5, pages 946-951.
Crossref
F. MEARIN, X. BADÍA, A. BALBOA, J. BENAVENT, A. M. CABALLERO, E. DOMÍNGUEZ‐MUÑOZ, V. GARRIGUES, J. M. PIQUÉ, M. ROSET, M. CUCALA & M. FIGUERAS. (2006) Predictive factors of irritable bowel syndrome improvement: 1‐year prospective evaluation in 400 patients. Alimentary Pharmacology & Therapeutics 23:6, pages 815-826.
Crossref
Georg Stacher & James Christensen. (2006) Visceral Hypersensitivity in Irritable Bowel Syndrome: A Summary Review. Digestive Diseases and Sciences 51:3, pages 440-445.
Crossref
Ala I. Sharara, Elie Aoun, Heitham Abdul-Baki, Rawad Mounzer, Shafik Sidani & Ihab ElHajj. (2006) A Randomized Double-Blind Placebo-Controlled Trial of Rifaximin in Patients with Abdominal Bloating and Flatulence. The American Journal of Gastroenterology 101:2, pages 326-333.
Crossref
P. M. Boyce, N. J. Talley, C. Burke & N. A. Koloski. (2005) Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population‐based study. Internal Medicine Journal 36:1, pages 28-36.
Crossref
E. B. ANDREWS, S. C. EATON, K. A. HOLLIS, J. S. HOPKINS, V. AMEEN, L. R. HAMM, S. F. COOK, P. TENNIS & A. W. MANGEL. (2005) Prevalence and demographics of irritable bowel syndrome: results from a large web‐based survey. Alimentary Pharmacology & Therapeutics 22:10, pages 935-942.
Crossref
R. Bruce Lydiard. (2014) Increased Prevalence of Functional Gastrointestinal Disorders in Panic Disorder: Clinical and Theoretical Implications. CNS Spectrums 10:11, pages 899-908.
Crossref
K.‐a. Gwee. (2005) Irritable bowel syndrome in developing countries – a disorder of civilization or colonization?. Neurogastroenterology & Motility 17:3, pages 317-324.
Crossref
C.‐L. Lu, F.‐Y. Chang, H.‐C. Lang, C.‐Y. Chen, J.‐C. Luo & S.‐D. Lee. (2005) Gender difference on the symptoms, health‐seeking behaviour, social impact and sleep quality in irritable bowel syndrome: a Rome II‐based survey in an apparent healthy adult Chinese population in Taiwan. Alimentary Pharmacology & Therapeutics 21:12, pages 1497-1505.
Crossref
George F. Longstreth. (2005) Definition and Classification of Irritable Bowel Syndrome: Current Consensus and Controversies. Gastroenterology Clinics of North America 34:2, pages 173-187.
Crossref
Filippo Cremonini & Nicholas J. Talley. (2005) Irritable Bowel Syndrome: Epidemiology, Natural History, Health Care Seeking and Emerging Risk Factors. Gastroenterology Clinics of North America 34:2, pages 189-204.
Crossref
Magda Guilera, Agustín Balboa & Fermín Mearin. (2005) Bowel Habit Subtypes and Temporal Patterns in Irritable Bowel Syndrome: Systematic Review. The American Journal of Gastroenterology 100:5, pages 1174-1184.
Crossref
Mónica Perona, Ruth Benasayag, Antonia Perelló, Javier Santos, Natalia Zárate, Patricia Zárate & Fermín Mearin. (2005) Prevalence of Functional Gastrointestinal Disorders in Women Who Report Domestic Violence to the Police. Clinical Gastroenterology and Hepatology 3:5, pages 436-441.
Crossref
A. D. Sperber, P. Shvartzman, M. Friger & A. Fich. (2005) Unexpectedly low prevalence rates of IBS among adult Israeli Jews. Neurogastroenterology & Motility 17:2, pages 207-211.
Crossref
Ami D. Sperber, Michael Friger, Pesach Shvartzman, Muhammed Abu-Rabia, Rasmieh Abu-Rabia, Muhammed Abu-Rashid, Khalil Albedour, Othaman Alkranawi, Alex Eisenberg, Alex Kazanoviz, Liyobov Mazingar & Alex Fich. (2005) Rates of functional bowel disorders among Israeli Bedouins in rural areas compared with those who moved to permanent towns. Clinical Gastroenterology and Hepatology 3:4, pages 342-348.
Crossref
J. Y. Kang. (2005) Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 21:6, pages 663-676.
Crossref
François Guillemot, Philippe Ducrotté & Lionel Bueno. (2005) Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal reflux disease in general practice. Gastroentérologie Clinique et Biologique 29:3, pages 243-246.
Crossref
D. Lesbros‐Pantoflickova, P. Michetti, M. Fried, C. Beglinger & A. L. Blum. (2004) Meta‐analysis: the treatment of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 20:11-12, pages 1253-1269.
Crossref
Michel Dapoigny, J??r??me Bellanger, Bruno Bonaz, Stanislas Bruley des Varannes, Lionel Bueno, Beno??t Coffin, Philippe Ducrott??Bernard Flouri??Marc L??mann, Anne Lepicard & Olivier Reigneau. (2004) Irritable bowel syndrome in France. European Journal of Gastroenterology & Hepatology 16:10, pages 995-1001.
Crossref
M. T. Hillilä & M. A. Färkkilä. (2004) Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non‐selected adult population. Alimentary Pharmacology & Therapeutics 20:3, pages 339-345.
Crossref
SELMAN CELEBI, YASEMIN ACIK, S ERHAN DEVECI, I HALIL BAHCECIOGLU, AHMET AYAR, ALI DEMIR & POLAT DURUKAN. (2004) Epidemiological features of irritable bowel syndrome in a Turkish urban society. Journal of Gastroenterology and Hepatology 19:7, pages 738-743.
Crossref
Gilles Bommelaer, Thierry Poynard, Claude Le Pen, Anne-Fran?oise Gaudin, Fr?d?rique Maurel, Ga?l Priol, Michel Amouretti, Jacques Frexinos, Philippe Ruszniewski & Abdelkader El Hasnaoui. (2004) Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroent?rologie Clinique et Biologique 28:6-7, pages 554-561.
Crossref
A Haim, G Pillar, A Pecht, A Lerner, N Tov, M Jaffe & D Hardoff. (2007) Sleep patterns in children and adolescents with functional recurrent abdominal pain: objective versus subjective assessment. Acta Paediatrica 93:5, pages 677-680.
Crossref
Kok-Ann Gwee, Sharon Wee, Mee-Lian Wong & Damian J C Png. (2004) The Prevalence, Symptom Characteristics, and Impact of Irritable Bowel Syndrome in an Asian Urban Community. The American Journal of Gastroenterology 99:5, pages 924-931.
Crossref
M. Mnguez Prez, B. Herreros Martnez, F. Mora Miguel & A. Benages Martnez. (2004) S?ndrome del intestino irritable. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 9:4, pages 246-252.
Crossref
S. L. S. Halder, G. R. LockeIIIIII, N. J. Talley, S. L. Fett, A. R. Zinsmeister & L. J. MeltonIIIIII. (2004) Impact of functional gastrointestinal disorders on health‐related quality of life: a population‐based case–control study. Alimentary Pharmacology & Therapeutics 19:2, pages 233-242.
Crossref
Fermin Mearin, Montse Roset, Xavier Badía, Agustin Balboa, Eva Baró, Julio Ponce, Manuel Díaz-Rubio, Ellen Caldwell, Mercedes Cucala, Arturo Fueyo & Nicholas J Talley. (2004) Splitting Irritable Bowel Syndrome: From Original Rome to Rome II Criteria. American Journal of Gastroenterology 99:1, pages 122-130.
Crossref
Fermin Mearin, Eva Baró, Montse Roset, Xavier Badía, Natalia Zárate & Isabel Pérez. (2004) Clinical Patterns Over Time in Irritable Bowel Syndrome: Symptom Instability and Severity Variability. American Journal of Gastroenterology 99:1, pages 113-121.
Crossref
G. D. Eslick, S. C. Howell, J. Hammer & N. J. Talley. (2003) Empirically derived symptom sub‐groups correspond poorly with diagnostic criteria for functional dyspepsia and irritable bowel syndrome. A factor and cluster analysis of a patient sample. Alimentary Pharmacology & Therapeutics 19:1, pages 133-140.
Crossref
Benoit Coffin, Michel Dapoigny, Denis Cloarec, Denis Comet & François Dyard. (2004) Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome. Gastroentérologie Clinique et Biologique 28:1, pages 11-15.
Crossref
C.‐L. Lu, C.‐Y. Chen, H.‐C. Lang, J.‐C. Luo, S.‐S. Wang, F.‐Y. Chang & S.‐D. Lee. (2003) Current patterns of irritable bowel syndrome in Taiwan: the Rome II questionnaire on a Chinese population. Alimentary Pharmacology & Therapeutics 18:11-12, pages 1159-1169.
Crossref
Y. A. Saito, N. J. Talley, L. J. MeltonIIIIII, S. Fett, A. R. Zinsmeister & G. R. LockeIIIIII. (2003) The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterology & Motility 15:6, pages 687-694.
Crossref
Sally D. Parry, Sally Corbett, Peter J. James, Roger Barton & Mark R. Welfare. (2016) Illness Perceptions in People with Acute Bacterial Gastro-Enteritis. Journal of Health Psychology 8:6, pages 693-704.
Crossref
M. Delvaux. (2003) Functional bowel disorders and irritable bowel syndrome in Europe. Alimentary Pharmacology & Therapeutics 18:s3, pages 75-79.
Crossref
Sally D. Parry, Rosamund Stansfield, Diana Jelley, Wendy Gregory, Elizabeth Phillips, J. Roger Barton & Mark R. Welfare. (2003) Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. The American Journal of Gastroenterology 98:9, pages 1970-1975.
Crossref
Adriane I Budavari & Kevin W Olden. (2003) Psychosocial aspects of functional gastrointestinal disorders. Gastroenterology Clinics of North America 32:2, pages 477-506.
Crossref
Samuel C. Somers & Anthony Lembo. (2003) Irritable bowel syndrome: evaluation and treatment. Gastroenterology Clinics of North America 32:2, pages 507-529.
Crossref
A. P. S. Hungin, P. J. Whorwell, J. Tack & F. Mearin. (2003) The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Alimentary Pharmacology & Therapeutics 17:5, pages 643-650.
Crossref
Fermín Mearin, Agustín Balboa, Xavier Badía, Eva Baró, Ellen Caldwell, Mercedes Cucala, Manuel Díaz-Rubio, Arturo Fueyo, Julio Ponce, Montse Roset & Nicholas J Talley. (2003) Irritable bowel syndrome subtypes according to bowel habit. European Journal of Gastroenterology & Hepatology 15:2, pages 165-172.
Crossref
Catherine Crane & Maryanne Martin. (2002) Perceived vulnerability to illness in individuals with irritable bowel syndrome. Journal of Psychosomatic Research 53:6, pages 1115-1122.
Crossref
Gervais Tougas. (2002) The Nature of Pain in Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 35:Supplement, pages S26-S30.
Crossref
Xavier Badia, Fermin Mearin, Agustin Balboa, Eva Bar??Ellen Caldwell, Mercedes Cucala, Manuel D??az-Rubio, Arturo Fueyo, Julio Ponce, Mentse Roset & Nicholas J. Talley. (2002) Burden of Illness in Irritable Bowel Syndrome Comparing Rome I and Rome II Criteria. PharmacoEconomics 20:11, pages 749-758.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.